Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cells
- 11 January 2011
- journal article
- Published by Springer Nature in Investigational New Drugs
- Vol. 30 (3) , 1248-1256
Abstract
This study sought to measure the degree of synergy induced by specific small molecule inhibitors of DNA-PK [NU7026 and IC486241 (ICC)], a major component of the non-homologous end-joining (NHEJ) pathway, with SN38 or oxaliplatin. Synergy between the DNA damaging drugs and the DNA-PK inhibitors was assessed using the sulforhodamine-B assay (SRB). Effects of drug combinations on cell cycle and DNA-PK activity were determined using flow cytometry and western blot analysis. DNA damage was assessed via comet assay and quantification of γH2AX. The role of homologous recombination repair (HRR) was determined by nuclear Rad51 protein levels and a GFP reporter recombination assay. Significant reductions in the IC50 values of SN38 were observed at 5 and 10 μM of DNA-PK inhibitors. Moreover, at 1–2 μM (attainable concentrations with ICC in mice) these DNA-PKcs inhibitors demonstrated synergistic reductions in the IC50 of SN38. Flow cytometric data indicated that SN38 and SN38 in combination with DNA-PKcs inhibitors showed dramatic G2/M arrest at 24 h. Furthermore, reduced phosphorylation of DNA-PKcs and increased DNA damage were observed at this time point with SN38 in combination with DNA-PKcs inhibitors as compared to cells treated with SN38 alone. SN38 alone and in the presence of ICC increased nuclear Rad51 protein levels. Furthermore, inhibition of DNA-PKcs increased HRR suggesting that NHEJ is a negative regulator of HRR. These data indicate that small molecule inhibitors of DNA-PKcs dramatically enhance the efficacy of SN38 in colon cancer cell lines.Keywords
This publication has 50 references indexed in Scilit:
- DNA damage signaling in response to double-strand breaks during mitosisJournal of Cell Biology, 2010
- The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining PathwayAnnual Review of Biochemistry, 2010
- ATM- and ATR-mediated response to DNA damage induced by a novel camptothecin, ST1968Cancer Letters, 2010
- Optimal Delivery of Cytotoxic Chemotherapy for Colon CancerThe Cancer Journal, 2010
- DNA Double-Strand Break Formation upon UV-Induced Replication Stress Activates ATM and DNA-PKcs KinasesJournal of Molecular Biology, 2009
- Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell linesBiochemical Pharmacology, 2008
- Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trialThe Lancet, 2007
- Chlorambucil Cytotoxicity in Malignant B Lymphocytes Is Synergistically Increased by 2-(Morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-Mediated Inhibition of DNA Double-Strand Break Repair via Inhibition of DNA-Dependent Protein KinaseThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Defective Mre11-dependent Activation of Chk2 by Ataxia Telangiectasia Mutated in Colorectal Carcinoma Cells in Response to Replication-dependent DNA Double Strand BreaksJournal of Biological Chemistry, 2006
- ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responsesCarcinogenesis, 2003